Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.49 - $0.61 $63,602 - $79,178
-129,800 Reduced 17.96%
592,800 $361,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $0.93 $0 - $345,402
371,400 Added 105.75%
722,600 $311,000
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.89 $22,192 - $51,976
58,400 Added 19.95%
351,200 $284,000
Q1 2022

May 16, 2022

SELL
$0.58 - $0.86 $22,272 - $33,024
-38,400 Reduced 11.59%
292,800 $176,000
Q4 2021

Feb 14, 2022

SELL
$0.73 - $1.28 $4,818 - $8,448
-6,600 Reduced 1.95%
331,200 $272,000
Q3 2021

Nov 15, 2021

SELL
$0.77 - $4.91 $139,062 - $886,746
-180,600 Reduced 34.84%
337,800 $268,000
Q2 2021

Aug 11, 2021

SELL
$2.18 - $4.66 $111,180 - $237,660
-51,000 Reduced 8.96%
518,400 $2.4 Million
Q1 2021

May 17, 2021

BUY
$1.3 - $3.24 $670,150 - $1.67 Million
515,500 Added 956.4%
569,400 $1.48 Million
Q3 2020

Nov 16, 2020

BUY
$0.67 - $1.4 $29,011 - $60,619
43,300 Added 408.49%
53,900 $75,000
Q2 2020

Aug 14, 2020

SELL
$0.52 - $0.87 $1,560 - $2,610
-3,000 Reduced 22.06%
10,600 $8,000
Q3 2019

Nov 14, 2019

BUY
$1.04 - $1.51 $14,144 - $20,536
13,600 New
13,600 $16,000
Q4 2018

Feb 14, 2019

SELL
$0.96 - $2.04 $274,272 - $582,828
-285,700 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.54 - $2.38 $213,752 - $330,344
138,800 Added 94.49%
285,700 $614,000
Q2 2018

Aug 14, 2018

BUY
$1.04 - $3.29 $152,776 - $483,301
146,900 New
146,900 $286,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.